Biological Bank for Atrial Fibrillation and Stroke
Recruiting
Observational Study
Stroke
Atrial Fibrillation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Hospices Civils de Lyon · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. This arrhythmia is responsible for 15% of strokes and more than 30% of strokes on people over 65 years.
According to studies, 30 to 40% of isolated atrial fibrillations could be familial. Atrial fibrillation has significant genetic heterogeneity. About 40 genes have been identified as potentially invo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Group 1a
* Inclusion Criteria :
\- AF history
* Exclusion Criteria :
* No AF history
* patient who didn't signed consent
Group 1b
* Inclusion Criteria :
* AF history
* Scheduled electrophysiological exploration or AF ablation
* Exclusion Criteria :
* No AF history
* pregnant wom…
Contacts